Oscar Health (OSCR) Price to Earnings (2021 - 2026)

Oscar Health (OSCR) has reported Price to Earnings for 6 consecutive years, with 21.55 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Earnings rose 203.03% year-over-year to 21.55; the trailing twelve-month figure through Jun 2026 stood at 14.15 (up 147.58% YoY), and the FY2025 full-year result was 8.5, down 107.68% from the prior year.
• Price to Earnings climbed to 21.55 in Q2 2026 per OSCR's latest filing, from 4.45 in the prior quarter.
• Across five years, Price to Earnings topped out at 57.92 in Q2 2024 and bottomed at 97.6 in Q2 2023.
• Historically, Price to Earnings has averaged 13.6 across 5 years, with a median of 11.26 in 2023.
• The sharpest annual moves came in 2023 and 2026: Price to Earnings tumbled 1354.5% in 2023, then jumped 203.03% in 2026.
• Over 5 years, Price to Earnings stood at 1.97 in 2022, then plunged by 501.82% to 11.84 in 2023, then slumped by 59.21% to 18.85 in 2024, then surged by 43.36% to 10.68 in 2025, then soared by 301.85% to 21.55 in 2026.
• According to Business Quant data, Price to Earnings over the past three periods registered 21.55, 4.45, and 10.68 for Q2 2026, Q1 2026, and Q4 2025 respectively.